Supporting drug reimbursement decision-making in Asia with RWD and RWE with the REALISE framework: an interview with Hwee-Lin Wee, National University of Singapore
![An image of Hwee-Lin Wee on a background of a map of Asia, next to the title 'Supporting drug reimbursement decision-making in Asia with RWD and RWE with the REALISE framework: an interview with Hwee-Lin Wee, National University of Singapore'. To represent that Hwee-Lin Wee discusses REALISE.](https://www.evidencebaseonline.com/wp-content/uploads/2024/03/Hwee-Lin.png)
Collaboration amongst stakeholders is key to advancing the use of real-world data (RWD) and real-world evidence (RWE) in regulatory and health technology assessment (HTA) decision-making processes. Recently the REAL World Data In ASia for HEalth Technology Assessment in Reimbursement (REALISE) working group developed a new framework for the generation and use of RWD and RWE in HTA in Asia. In this interview, we speak with Hwee-Lin Wee (National University of Singapore) to learn more about REALISE and their work in developing this new guidance. Please could you introduce yourself and your background? I am Associate Professor at the Saw Swee...